WeVote
Log In

Bill

Bill

SB 39

Cosmetic safety: vaginal suppositories.

2025-2026 Regular Session Introduced by Akilah Weber Pierson

California requires vaginal suppository manufacturers to disclose ingredients and allergens, establishing safety standards for cosmetic products in this previously unregulated category.

Chaptered by Secretary of State. Chapter 208, Statutes of 2025.
#cosmeticsafety #vaginalsuppositories
0
WeVote Research Nonpartisan
Bill Summary · SB 39

Legislative bill overview

SB 39 establishes new safety and labeling requirements for vaginal suppositories marketed as cosmetic products in California. The bill requires manufacturers to disclose ingredients, list potential allergens, and comply with specific safety standards before these products can be sold to consumers.

Why is this important

Vaginal suppositories fall into a regulatory gray area between cosmetics and medical devices, leaving consumers vulnerable to unlabeled ingredients and unverified safety claims. This legislation addresses a gap in consumer protection by ensuring transparency and standardized safety measures for products used in sensitive areas of the body, potentially preventing allergic reactions and adverse health effects.

Potential points of contention

  • Regulatory burden on manufacturers: Small businesses producing vaginal suppositories may face increased compliance costs and reformulation expenses to meet new labeling and ingredient disclosure requirements
  • Definition ambiguity: The distinction between "cosmetic" vaginal suppositories and medical devices remains complex; unclear boundaries could create compliance confusion and inconsistent enforcement
  • Market impact: Stricter requirements could reduce product availability or increase consumer prices, particularly affecting independent or smaller brands in the wellness market

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.